Output details
4 - Psychology, Psychiatry and Neuroscience
University of Cambridge
Return to search
Output 0 of 0 in the submission
Article title
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: A randomised controlled phase 3 trial
Type
D - Journal article
Title of journal
The Lancet
Article number
-
Volume number
380
Issue number
9856
First page of article
1829
ISSN of journal
0140-6736
Year of publication
2012
URL
-
Number of additional authors
17
Additional information
-
Interdisciplinary
-
Cross-referral requested
-
Research group
None
Citation count
41
Proposed double-weighted
No
Double-weighted statement
-
Reserve for a double-weighted output
No
Non-English
No
English abstract
-